Sort
23,748 grants matching “melanoma”
The role of structural variation in promotion, evolution and treatment of various tumor types
$408,350Mikhail Kolmogorov · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA
A Regulatory Triad: IL35, Tregs and iTr35
$408,100Dario Aa Vignali · University Of Pittsburgh At Pittsburgh · R01 · FY2015 · AI
UCHL5 as a regulator and therapeutic target in metastatic melanoma
$408,096Kunal Rai · University Of Tx Md Anderson Can Ctr · R01 · FY2020 · CA
Improving Melanoma Pathology Accuracy through Computer Vision Techniques - the IMPACT Study
$408,063Joann G Elmore · University Of Washington · R01 · FY2016 · CA
Project 3: Efficacy of MEK Inhibition in Juvenile Myelomonocytic Leukemia
$408,012Kevin M Shannon · Indiana University Indianapolis · U54 · FY2016 · CA
Imaging Mitochondrial Redox States In Vivo by Hyperpolarized MR
$407,904Lin Z Li · University Of Pennsylvania · R01 · FY2011 · CA
NanoOptogenetic immunotherapy for B cell lymphoma
$407,858Gang Han · Univ Of Massachusetts Med Sch Worcester · R01 · FY2023 · CA
Targeted Chemoprevention for Melanoma
$407,854Gavin P. Robertson · Pennsylvania State Univ Hershey Med Ctr · R01 · FY2012 · CA
ISG15 and Protein ISGylation in Cancer
$407,842Dong-Er Zhang · University Of California, San Diego · R01 · FY2022 · CA
Mutant BRAF as a Therapeutic Target for Melanoma
$407,790Dorothee M Herlyn · Wistar Institute · P01 · FY2009 · CA
Exploratory Study of T Cell Skin Trafficking and the Role of NKG2D Signaling; Implications in Vitiligo and Melanoma
$407,770Jose Alejandro Guevara-Patino · H. Lee Moffitt Cancer Ctr & Res Inst · R21 · FY2023 · AR
Cancer Biology in the Zebrafish
$407,763Leonard I Zon · Boston Children'S Hospital · R01 · FY2019 · CA
The role of genetic susceptibility in melanoma development
$407,725Meenhard Herlyn · Wistar Institute · R01 · FY2016 · CA
Multiple Tumor Antigen-loaded DC Vaccine for Hepatocellular Cancer
$407,715Lisa Helene Butterfield · University Of Pittsburgh At Pittsburgh · R01 · FY2012 · CA
Improving response to immunotherapy by genistein and antiestrogens
$407,663Leena A Hilakivi-Clarke · University Of Minnesota · R21 · FY2021 · CA
Preclinical Development of PEG-TNF
$407,578Phoenix Pharmacologics, Inc. · R44 · FY2005 · CA
The role of the CD58:CD2 axis in cancer immune evasion and resistance to immunotherapy
$407,530Benjamin Izar · Columbia University Health Sciences · R01 · FY2022 · CA
Beta glucan enhances antibody therapy for neuroblastoma
$407,500Sloan-Kettering Institute For Cancer Res · R21 · FY2002 · CA
Beta glucan enhances antibody therapy for neuroblastoma
$407,500Sloan-Kettering Institute For Cancer Res · R21 · FY2003 · CA
Modulation of Anti-Tumor Immunity by Inhibitory Receptors
$407,472Dario Aa Vignali · University Of Pittsburgh At Pittsburgh · P01 · FY2017 · AI
Cellular and molecular regulators of melanocyte regeneration
$407,435Craig Joseph Ceol · Univ Of Massachusetts Med Sch Worcester · R56 · FY2022 · AR
Multi-color Mapping of Cancer Molecular Signatures and Tumor microenvironment
$407,268Jenny J Yang · Georgia State University · R33 · FY2019 · CA
Rewired Metabolism Regulates Vessel Normalization and Immunosuppression
$407,228Xiang Zhang · Baylor College Of Medicine · R01 · FY2022 · CA
Rewired Metabolism Regulates Vessel Normalization and Immunosuppression
$407,228Xiang Zhang · Baylor College Of Medicine · R01 · FY2023 · CA
RNA-Based Immunotherapy Targeting Antigens Unique to Brain Tumor Stem Cells
$407,160John H Sampson · Duke University · R01 · FY2009 · CA